Transatlantic medevac is one of the most demanding mission profiles. Long range, weather routing, customs and admission paperwork all need to align — and they do, when planned properly.
US ground ambulance vetted at both coasts and major hubs; customs and immigration coordinated via FBO.
Transatlantic missions are typically among the highest-cost flights; route planning, fuel stops and aircraft selection drive the variance.
See pricing guide →Coordination with major US academic medical centres and private hospitals.
The United States is the world's deepest medical aviation market by aircraft and operator volume and one of the most operationally complex by clinical, financial and regulatory standard. Air ambulance traffic into and out of the US is dominated by long-range jet repatriation, inbound second-opinion treatment at US specialist centres, and inter-hospital transfers between the country's tertiary networks.
The United States hosts more fixed-wing medical operators, more aircraft and more medical flight hours per year than any other country. The structural reason is the size of the domestic inter-hospital transfer market: US tertiary centres routinely accept patients from other states for transplant, oncology, cardiac surgery, neurosurgery, burns and paediatric specialty care, and the distances involved make fixed-wing air transfer the standard rather than the exception. Layered on top of this domestic flow is a smaller but high-value international flow: inbound patients seeking specialist treatment, outbound repatriation of US nationals from abroad, and inbound repatriation of foreign nationals treated in the US.
US receiving capability is exceptional and well-known to international referrers. The Mayo Clinic (Rochester, Jacksonville, Phoenix), Cleveland Clinic, Johns Hopkins, MD Anderson, Memorial Sloan Kettering, Massachusetts General, Brigham and Women's, the UCSF medical centre, Stanford, UCLA, Cedars-Sinai, NewYork-Presbyterian, Mount Sinai, Duke, Vanderbilt, Northwestern, Rush, Children's Hospital of Philadelphia, Boston Children's, Texas Children's and the rest of the top-thirty US academic medical centres form a working network of receiving facilities for international patients. The selection of receiving hospital for an inbound international patient is normally driven by the specific clinical need, the consultant's referral, the family's insurance or self-pay position and any pre-existing relationship between the patient's home consultant and the US receiving team.
The cost dimension of US healthcare is its own subject and is not specific to medevac. We will say only what is operationally relevant: receiving hospitals require financial clearance before they accept an international inbound patient, and that clearance is normally settled between the family, the insurer or sponsor and the hospital's international patient department before the flight is launched. We will not lift a transatlantic or transpacific repatriation into a US hospital without that clearance in writing.
Inbound to the US: international patients arriving for specialist treatment (oncology, transplant, paediatric specialty care, advanced cardiac), often from the Middle East, Latin America, the Caribbean and Asia; repatriation of US nationals from Europe, Latin America, Asia and the Caribbean after illness or injury abroad; and inter-hospital transfers from foreign hospitals to US tertiary centres for specific clinical reasons.
Outbound from the US: repatriation of foreign nationals treated in the US who are now stable enough to return home, often to Europe, Latin America or the Middle East; and transfer of US patients to specialist centres elsewhere (rare, but it happens — notably for some paediatric specialty care and for end-of-life return to a home country).
Within the US, the dominant pattern is inter-hospital transfer between tertiary centres, predominantly between major metropolitan medical hubs and smaller regional hospitals. This domestic market is large and well-served by the US fixed-wing medical operator base; international brokers like us coordinate cross-border missions rather than competing with domestic operators for in-country work.
Long-range jets do the bulk of transatlantic and transpacific medevac into and out of the US. The Challenger 604/605, Global 5000/6000, Gulfstream G450/G550 and Falcon 7X cover most routes; the Bombardier Global 7500 and Gulfstream G650 cover the longest sectors directly. Routing from western Europe to the US east coast is typically direct or via a technical stop in Iceland or Goose Bay; from southern Europe via the Azores; from the Middle East to the US east coast via a technical stop in western Europe; from Asia to the US west coast direct in a Global or Gulfstream long-range or via Anchorage in a shorter-range airframe.
Technical stops in medical aviation are not unusual and are not a quality compromise. They allow the medical team to refresh the patient's clinical configuration on the ground, replenish oxygen and consumables, and reset crew duty time. The decision between direct and technical-stop routing is made by the operator's flight department in consultation with the medical director, based on weight, weather, patient stability and crew duty law.
For inbound and outbound patients who do not require a long-range jet — for example, a stable post-cardiac patient travelling on a commercial medical escort basis with a clinical companion — we will arrange the commercial routing in business or first class with a properly qualified medical escort. This is a different category of transport from a dedicated air ambulance flight, and it is appropriate for a specific clinical sub-set.
We act as a charter broker under the framework set out in 14 CFR Part 295. That regulation places specific disclosure obligations on US-based brokers, including written identification of the operating air carrier, disclosure of the aircraft, and disclosure of total charge for the air transportation before the customer is asked to pay. We do not operate aircraft, we do not exercise operational control, we do not represent that we operate the aircraft, and we are not a direct air carrier under 14 CFR Part 119 or any equivalent regulation. The operating air carrier is identified in writing before any payment is collected. For full detail of our broker status see our disclosures page.
We do not maintain broker errors-and-omissions insurance, and we disclose that fact under 14 CFR Part 295. The operating air carriers we coordinate with carry the aircraft and passenger liability cover required by their certification and by the contracts the customer enters with them directly.
Transatlantic US repatriation by long-range jet typically costs significantly more than an intra-European mission because of the airframe category, the crew duty profile, the fuel volume and the technical-stop infrastructure. Routes from western Europe to the US east coast are at the lower end of the band; routes from southern Europe or the Middle East to the US west coast sit at the upper end. Indicative figures are provided in our air ambulance cost guide, but every transatlantic mission is priced case by case.
Within-US sectors are priced in line with the domestic US medical aviation market and are typically lower per hour than transatlantic work because the airframe category required is smaller. Inter-hospital transfers between, say, Miami and New York, or between Houston and Boston, are routinely flown in a Learjet, Citation or Hawker rather than in a Challenger or Global.
Indicative cost bands for air ambulance USA — by aircraft category, routing distance and clinical configuration.
Tell us where the patient is. We do the rest.
Typically 7–9 hours block time eastbound and a little longer westbound, plus customs and ground transfers.
Yes — pre-cleared via the destination FBO, with patient and crew documents prepared in advance.